Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 14, 2018
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
[ Wed, Nov 14th 2018
] - WOPRAI
Anupam Rama Maintained (APLS) at Buy with Decreased Target to $34 on, Nov 14th, 2018
Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Decreased Target from $38 to $34 on, Nov 14th, 2018.
Anupam has made no other calls on APLS in the last 4 months.
There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Anupam
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $40 on, Thursday, September 13th, 2018
- Elemer Piros of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $53 on, Wednesday, August 8th, 2018
Similar Stocks and Investing Articles
[ Tue, Oct 16th 2018
] - WOPRAI
[ Fri, Sep 28th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Sep 22nd 2016
] - WOPRAI
[ Wed, Sep 14th 2016
] - WOPRAI